02.04.2015 • News • Elaine Burridge • Mergers & Acquisitions (M&A) • DSM

Sale of DSM Synres Completed

Dutch life sciences and materials sciences company DSM has finalised the sale of DSM Synres to private equity firm Standard Investment. Financial details of the sale, which was announced on December 17 last year, were not disclosed.

DSM Synres produces solvent-borne alkyd and acrylic coating resins at its site in Hoek van Holland for the global coatings, adhesives and graphic arts markets. It has sales of around €50 million and about 80 employees.

Standard Investment, based in Amsterdam, focuses on small and medium-sized enterprises in the Netherlands and Belgium. It has acquired 18 companies since its establishment in 2004.

Free Virtual Event

Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.